Patents Assigned to CALIFORNIA CAPITAL EQUITY, LLC
  • Pyridyl-Triazine Inhibitors of Hedgehog Signaling
    Publication number: 20120277233
    Abstract: The invention provides pyridyl-triazine derivatives to inhibit the hedgehog signaling pathway and the use of such compounds in the treatment of hyperproliferative diseases and angiogenisis mediated diseases.
    Type: Application
    Filed: June 8, 2010
    Publication date: November 1, 2012
    Applicant: California Capital Equity, LLC
    Inventors: Chunlin Tao, Hongna Han, Xiaowen Sun, Neil Desai
  • Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
    Publication number: 20120270858
    Abstract: The invention provides isoquinoline, quinoline, and quinazoline derivatives to treat a variety of disorders, diseases and pathologic conditions, and more specifically to the use of isoquinoline, quinoline, and quinazoline derivatives to inhibit the hedgehog signaling pathway and to the use of those compounds to the treatment of hyperproliferative diseases and pathologic angiogenesis.
    Type: Application
    Filed: June 9, 2010
    Publication date: October 25, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Xiaowen Sun, Hongna Han, Lukasz Koroniak, Neil Desai
  • BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120264759
    Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
    Type: Application
    Filed: June 8, 2010
    Publication date: October 18, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, David Ho, Laxman Nallan, Tulay Polat, Xiaowen Sun, Neil Desai
  • Triazine Derivatives and their Therapeutical Applications
    Publication number: 20120238576
    Abstract: The present invention comprises inter alia compounds as shown in formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 7, 2010
    Publication date: September 20, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Laxman Nallan, Tulay Polat, Lukasz Koroniak, Neil Desai
  • UREIDOPHENYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120202818
    Abstract: The present invention provides Uredophenyl substituted triazine derivatives and provides methods of using these compounds to modulate protein kinases and methods of using these compounds to treat protein kinase mediated diseases and conditions.
    Type: Application
    Filed: June 9, 2010
    Publication date: August 9, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Lukasz Koroniak, Laxman Nallan, Neil Desai
  • Triazine derivatives and their therapeutical applications
    Publication number: 20120196860
    Abstract: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
    Type: Application
    Filed: June 9, 2010
    Publication date: August 2, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Laxman Nallan, Tulay Polat, David Ho, Neil Desai
  • STYRYL-TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120178758
    Abstract: The invention provides Styryl-Triazine derivatives, and further provides methods of using these compounds to modulate protein kinases and to treat protein kinase mediated diseases.
    Type: Application
    Filed: June 8, 2010
    Publication date: July 12, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Neil Desai
  • TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS
    Publication number: 20120172361
    Abstract: Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 7, 2010
    Publication date: July 5, 2012
    Applicant: CALIFORNIA CAPITAL EQUITY, LLC
    Inventors: Chunlin Tao, Qinwei Wang, Tulay Polat, Laxman Nallan, David Ho, Neil Desai